Recombinant Coagulation Factor VIII for Injection

神州细胞工程有限公司🇨🇳 National Medical Products Administration

Approval Id: 89Gv3YRX5pn
Approval Number: 国药准字S20210031
Generic Name: 注射用重组人凝血因子Ⅷ
Generic Name En: Recombinant Coagulation Factor VIII for Injection
Trade Name: 安佳因
Drug Type: 生物制品
Dosage Form: 注射剂
Strength: 250IU/瓶
Reg Date: 2021-07-20
Company Name: 神州细胞工程有限公司
Company Address: 北京市北京经济技术开发区科创七街31号院5号楼301室
Production Company Name: 神州细胞工程有限公司
Production Company Address: 北京市大兴区北京经济技术开发区科创七街31号院
Company Detail Path: /organization/shen-zhou-xi-bao-gong-cheng-you-xian-gong-si
Production Company Detail Path: /organization/shen-zhou-xi-bao-gong-cheng-you-xian-gong-si

Approved

Agency

NMPA

Country

🇨🇳

Approval Date

Jul 20, 2021

Approval ID

89Gv3YRX5pn

Type

生物制品